First Time Loading...

Cullinan Oncology Inc
NASDAQ:CGEM

Watchlist Manager
Cullinan Oncology Inc Logo
Cullinan Oncology Inc
NASDAQ:CGEM
Watchlist
Price: 23.51 USD 3.16% Market Closed
Updated: Jun 1, 2024

Cullinan Oncology Inc
PP&E Gross

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Cullinan Oncology Inc
PP&E Gross Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive PP&E Gross Analysis
Latest Figures & CAGR of Competitors

Company PP&E Gross CAGR 3Y CAGR 5Y CAGR 10Y
Cullinan Oncology Inc
NASDAQ:CGEM
PP&E Gross
$3.5m
CAGR 3-Years
228%
CAGR 5-Years
78%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
PP&E Gross
$5B
CAGR 3-Years
-1%
CAGR 5-Years
9%
CAGR 10-Years
8%
Gilead Sciences Inc
NASDAQ:GILD
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Cullinan Oncology Inc's PP&E Gross?
PP&E Gross
3.5m USD

Based on the financial report for Dec 31, 2023, Cullinan Oncology Inc's PP&E Gross amounts to 3.5m USD.

What is Cullinan Oncology Inc's PP&E Gross growth rate?
PP&E Gross CAGR 5Y
78%

Over the last year, the PP&E Gross growth was -33%. The average annual PP&E Gross growth rates for Cullinan Oncology Inc have been 228% over the past three years , 78% over the past five years .